Skip to content

Stem Cells for Treating Critical Ischemia

the Use of Autogenous Adult Stem Cells in the Treatment of Critical Ischemia

Status
UNKNOWN
Phases
Phase 1
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT00488020
Enrollment
10
Registered
2007-06-19
Start date
2006-04-30
Completion date
2007-06-30
Last updated
2008-06-13

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Critical Limb Ischemia, Ischemic Ulcers

Keywords

rest pain, ischemic ulcers

Brief summary

Collection of bone marrow blood Selection of mononuclear cells dilution with albumin injection into the calf muscles through 40 shots

Detailed description

About 500cc of blood are collected from the iliac bone marrow under epidural anesthesia.In the cell therapy lab this blood is harvested and mononuclear cells are separated.This procedure takes roughly 4 hours.After dilution in albumin (40cc)the mononuclear cells are injected into the calf muscles through 40 shots.This procedure is indicated for patients with lower limb ischemia on whom all the others known therapies have failed

Interventions

PROCEDUREstem cells transplant

Sponsors

Instituto de Molestias Cardiovasculares
Lead SponsorOTHER

Study design

Allocation
NA
Intervention model
SINGLE_GROUP
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
30 Years to 80 Years
Healthy volunteers
No

Inclusion criteria

* Fontaine's classification grade 3 and 4 patients

Exclusion criteria

* Record of cancer in the last 5 years * Over 80 years * Diabetic retinopathy

Design outcomes

Primary

MeasureTime frame
Suppress pain and heal ischemic ulcers6 months

Secondary

MeasureTime frame
improve quality of life6 months

Countries

Brazil

Contacts

Primary ContactJose D Araújo, MD
imc.terapia.celular@terra.com.br551732034000

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026